Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair

Author： Markovic-Plese Silva   Singh Avtar K   Singh Inderjit  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.3, Iss.2, 2008-03, pp. : 153-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic cells in the CNS: immune regulators and therapeutic targets for multiple sclerosis treatment

By Zozulya Alla L   Reinke Emily K   Ling Changying   Sandor Matyas   Fabry Zsuzsanna  

Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. : 97-106

Future Medicine

Access to resources Recommend Favorite

Multiple sclerosis and immune regulatory cells

By Antel Jack   Owens Trevor  

Brain, Vol. 127, Iss. 9, 2004-09 ,pp. : 1915-1916

Oxford University Press

Access to resources Recommend Favorite

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride

By Arun Tarunya  

Brain, Vol. 136, Iss. 1, 2013-01 ,pp. : 106-115

Oxford University Press

Access to resources Recommend Favorite

Predicting a window of therapeutic opportunity in multiple sclerosis

By Andersen Oluf  

Brain, Vol. 133, Iss. 7, 2010-07 ,pp. : 1863-1865

Oxford University Press

Access to resources Recommend Favorite

Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis

By Ruprecht Klemens   Gronen Felix   Sauter Marlies   Best Barbara   Rieckmann Peter   Mueller-Lantzsch Nikolaus  

Journal of NeuroVirology, Vol. 14, Iss. 2, 2008-03 ,pp. : 143-151

Ashgate Publishing Ltd

Access to resources Recommend Favorite